T-Wave Alternans ICD Screening May Gain Traction With St. Jude Pact
This article was originally published in The Gray Sheet
Executive Summary
St. Jude Medical's endorsement of microvolt t-wave alternans testing under a co-marketing agreement with test maker Cambridge Heart will help accelerate adoption of the technology, which guides appropriate defibrillator patient selection, both companies say